These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
573 related items for PubMed ID: 30834619
1. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling. Fan HW, Ni Q, Fan YN, Ma ZX, Li YB. Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619 [Abstract] [Full Text] [Related]
2. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway. Wang Q, Shi M, Sun S, Zhou Q, Ding L, Jiang C, Bian T, Jia F, Liu Y, Qin J. Biochem Biophys Res Commun; 2020 Apr 09; 524(3):656-662. PubMed ID: 32033754 [Abstract] [Full Text] [Related]
3. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme. Mohajerani F, Tehrankhah ZM, Rahmani S, Afsordeh N, Shafiee S, Pourgholami MH, Soltani BM, Sadeghizadeh M. BMC Cancer; 2024 Jan 02; 24(1):19. PubMed ID: 38167030 [Abstract] [Full Text] [Related]
6. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Cheng Y, Xie P. J Biochem Mol Toxicol; 2019 Nov 02; 33(11):e22392. PubMed ID: 31503386 [Abstract] [Full Text] [Related]
10. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway. Xin J, Zhang XY, Sun DK, Tian LQ, Xu P. Eur Rev Med Pharmacol Sci; 2019 Apr 02; 23(8):3447-3454. PubMed ID: 31081099 [Abstract] [Full Text] [Related]
11. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y, Ma X, Wang Y, Li G. Biomed Pharmacother; 2017 Sep 02; 93():435-443. PubMed ID: 28666210 [Abstract] [Full Text] [Related]
12. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway. Liao YX, Zhang ZP, Zhao J, Liu JP. Cell Physiol Biochem; 2018 Sep 02; 48(3):1382-1396. PubMed ID: 30048971 [Abstract] [Full Text] [Related]
13. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway. Zheng Q, Diao S, Wang Q, Zhu C, Sun X, Yin B, Zhang X, Meng X, Wang B. J Cell Mol Med; 2019 Jan 02; 23(1):357-369. PubMed ID: 30353649 [Abstract] [Full Text] [Related]
14. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN. Zhu H, Liu Q, Tang J, Xie Y, Xu X, Huang R, Zhang Y, Jin K, Sun B. Cell Physiol Biochem; 2017 Jan 02; 41(6):2289-2306. PubMed ID: 28456796 [Abstract] [Full Text] [Related]
15. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44. Wang J, Li X, Wu H, Wang H, Yao L, Deng Z, Zhou Y. J Cell Biochem; 2019 Oct 02; 120(10):17142-17150. PubMed ID: 31111534 [Abstract] [Full Text] [Related]
16. Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway. Song W, Wang Z, Kan P, Ma Z, Wang Y, Wu Q, Yao X, Zhang B. Biomed Res Int; 2018 Oct 02; 2018():6953506. PubMed ID: 30420967 [Abstract] [Full Text] [Related]
17. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis. Cheng T, Xu Y. Med Sci Monit; 2018 Oct 11; 24():7249-7255. PubMed ID: 30305602 [Abstract] [Full Text] [Related]
18. Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway. Yin H, Deng Z, Li X, Li Y, Yin W, Zhao G, Jiang D, Sun C, Zhou Y. Cancer Genet; 2019 Sep 11; 237():1-9. PubMed ID: 31447061 [Abstract] [Full Text] [Related]
19. CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway. Liu X, Wu X, Wang Y, Li Y, Chen X, Yang W, Jiang L. Oncol Res; 2019 Mar 29; 27(4):415-422. PubMed ID: 29321087 [Abstract] [Full Text] [Related]